Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Human Gene Therapy|April 10, 2026
SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer CellsNikolaos Kontopoulos, Noémie Delenclos, Laetitia Ligat, et al.
European Journal of Medicinal Chemistry|April 21, 2024
Synthesis of LAVR-289, a new [(Z)-3-(acetoxymethyl)-4-(2,4-diaminopyrimidin-6-yl)oxy-but-2-enyl]phosphonic acid prodrug with pronounced antiviral activity against DNA virusesMaximes Bessières, Vincent Roy, Tuniyazi Abuduani, et al.
Frontiers in Plant Science|July 23, 2021
ANCHOR: A Technical Approach to Monitor Single-Copy Locus Localization in PlantaAnis Meschichi, Mathieu Ingouff, Claire Picart, et al.
ACS Infectious Diseases|May 17, 2025
LAVR-289, an Acyclo-Nucleoside Phosphonate, Has Broad-Spectrum Activity against HerpesvirusesSandrine Kappler-Gratias, Charlotte Quentin-Froignant, Elie Marcheteau, et al.
Viruses|January 8, 2020
Tracing Baculovirus AcMNPV Infection Using a Real-Time Method Based on ANCHORTM DNA Labeling TechnologyAurélie Hinsberger, Benoît Graillot, Christine Blachère Lopez, et al.
International Journal of Pharmaceutics|September 12, 2024
Lyotropic liquid crystal emulsions of LAVR-289: Influence of internal mesophase structure on cytotoxicity and in-vitro antiviral activityMathias Brouillard, Thomas Mathieu, Samuel Guillot, et al.
Biophysical Journal|October 6, 2017
Real-Time Imaging of a Single Gene Reveals Transcription-Initiated Local ConfinementThomas Germier, Silvia Kocanova, Nike Walther, et al.
ACS Infectious Diseases|May 19, 2025
LAVR-289, an Orally Bioavailable Inhibitor of Adenovirus Replication In Vitro and In VivoCharlotte Quentin-Froignant, Ann E Tollefson, Anna Cline-Smith, et al.
Human Gene Therapy|January 28, 2021
A Novel Imaging Approach for Single-Cell Real-Time Analysis of Oncolytic Virus Replication and Efficacy in Cancer CellsLorraine Quillien, Sokunthea Top, Sandrine Kappler-Gratias, et al.
International Journal of Molecular Sciences|January 11, 2024
A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial VirusAdrien Le Rouzic, Jenna Fix, Robin Vinck, et al.
Pageof 4